Olema Pharmaceuticals, Inc. OLMA Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s interest income?
- Olema Pharmaceuticals, Inc. (OLMA) reported interest income of $4.78M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s interest income changed year-over-year?
- Olema Pharmaceuticals, Inc.'s interest income increased by 5.6% year-over-year, from $4.52M to $4.78M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s interest income?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s interest income has grown at a 146.1% compound annual growth rate (CAGR), from $442K to $16.22M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.